Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
GE Aerospace
GE
|
$1.18B |
| 2 |
Fidelity National Information Services
FIS
|
$572M |
| 3 |
PayPal
PYPL
|
$535M |
| 4 |
Charles Schwab
SCHW
|
$430M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$419M |
Top Sells
| 1 |
Sanofi
SNY
|
$751M |
| 2 |
Bristol-Myers Squibb
BMY
|
$666M |
| 3 |
HP
HPQ
|
$615M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$534M |
| 5 |
GSK
GSK
|
$501M |
Sector Composition
| 1 | Financials | 22.19% |
| 2 | Healthcare | 18.97% |
| 3 | Technology | 16.22% |
| 4 | Communication Services | 14.67% |
| 5 | Energy | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Fresenius Medical Care
FMS
$15.1B
| $31.8M | 0.02% | 1,275,400 | – | – |
|
102
Eli Lilly
LLY
$657B
| $23.1M | 0.02% | 71,181 -1,532 | -2% | -$497K |
|
103
Travelers Companies
TRV
$61.1B
| $21.1M | 0.01% | 124,825 -1,260 | -1% | -$213K |
|
104
Target
TGT
$43.6B
| $18.9M | 0.01% | 133,989 -2,961 | -2% | -$418K |
|
105
Merck
MRK
$210B
| $17.6M | 0.01% | 192,831 -7,200 | -4% | -$656K |
|
106
Thermo Fisher Scientific
TMO
$186B
| $17.2M | 0.01% | 31,604 | – | – |
|
107
Procter & Gamble
PG
$368B
| $14.5M | 0.01% | 100,650 -2,425 | -2% | -$349K |
|
108
Halliburton
HAL
$19.4B
| $14.1M | 0.01% | 448,701 -138,175 | -24% | -$4.33M |
|
|
HES
109
DELISTED
Hess
HES
| $10.6M | 0.01% | 100,010 -16,350 | -14% | -$1.73M |
|
110
Walmart
WMT
$774B
| $10.4M | 0.01% | 85,465 -891 | -1% | -$108K |
|
111
APA Corp
APA
$8.31B
| $10.1M | 0.01% | 289,673 -90,710 | -24% | -$3.17M |
|
112
Adobe
ADBE
$151B
| $9.78M | 0.01% | 26,706 -300 | -1% | -$110K |
|
113
Home Depot
HD
$405B
| $8.2M | 0.01% | 29,906 -170 | -0.6% | -$46.6K |
|
114
Pfizer
PFE
$141B
| $7.65M | 0.01% | 145,885 | – | – |
|
115
Exxon Mobil
XOM
$487B
| $7.32M | 0.01% | 85,436 -1,886 | -2% | -$162K |
|
116
Analog Devices
ADI
$124B
| $6.13M | ﹤0.01% | 41,985 -377 | -0.9% | -$55.1K |
|
117
Apple
AAPL
$3.45T
| $5.63M | ﹤0.01% | 41,156 | – | – |
|
118
Caterpillar
CAT
$196B
| $5.62M | ﹤0.01% | 31,437 -70 | -0.2% | -$12.5K |
|
119
IBM
IBM
$227B
| $5.49M | ﹤0.01% | 38,914 -1,650 | -4% | -$233K |
|
120
Synopsys
SNPS
$112B
| $4.7M | ﹤0.01% | 15,484 -100 | -0.6% | -$30.4K |
|
121
Danaher
DHR
$147B
| $4.6M | ﹤0.01% | 18,142 | – | – |
|
122
Boston Scientific
BSX
$156B
| $4.49M | ﹤0.01% | 120,590 | – | – |
|
123
Johnson & Johnson
JNJ
$427B
| $4.43M | ﹤0.01% | 24,970 -401 | -2% | -$71.2K |
|
124
Vulcan Materials
VMC
$38.5B
| $4.1M | ﹤0.01% | 28,850 -1,000 | -3% | -$142K |
|
125
Amgen
AMGN
$155B
| $4.02M | ﹤0.01% | 16,507 -100 | -0.6% | -$24.3K |
|